← Leaderboards
Jyothi Unnikrishna Menon
University Of Rhode Island
$1,535,925
Attributed
$1,535,925
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $513.8K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,535,925 · 2
By mechanism
R37$1,122,488 · 1
R21$413,437 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rhode Island
Same institution · by research overlap
- Jill Kreiling$3,267,834
- Bongsup P Cho$14,666,128
- Hany Alashwal$592,467
- Ken Q Yang$3,002,058
- Niall George Howlett$20,248,993
Others in their field
Other Rising Stars on “Combined Modality Therapy”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Robert C Alexander · Banner Health$5,101,602
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Xu Chen · University Of California, San Francisco$3,581,285
- Stuart Marcus · Sonalasense Inc$3,491,029
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$3,437,655
Research focus
Combined Modality TherapyDesignCholestasisCollagenCessation Of LifeCytokineCellsBiological MarkersCirrhosisCollaborationsAlcoholic Liver DiseasesAgonistAlcoholsCoupledAlcohol AbuseCancer EtiologyAdverse EffectsAttenuatedChronicChronic Liver DiseaseBile AcidsClinicBiodistributionDrug Delivery Systems
Grant awards (6)
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development$423,869
R37 · FY2025 · CA · contact PI
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development$4,396
R37 · FY2025 · CA · contact PI
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development$406,851
R37 · FY2024 · CA · contact PI
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development$287,372
R37 · FY2023 · CA · contact PI
Nanoparticle-mediated targeting of hepatic macrophages to mitigate inflammation in alcoholic liver disease$226,406
R21 · FY2023 · AA · contact PI
Nanoparticle-mediated targeting of hepatic macrophages to mitigate inflammation in alcoholic liver disease$187,031
R21 · FY2022 · AA · contact PI